InvestorsObserver
×
News Home

Should You Add Heron Therapeutics Inc (HRTX) Stock to Your Portfolio Tuesday?

Tuesday, November 28, 2023 09:37 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Heron Therapeutics Inc (HRTX) Stock to Your Portfolio Tuesday?

Heron Therapeutics Inc (HRTX) is around the top of the Healthcare sector according to InvestorsObserver. HRTX received an overall rating of 33, which means that it scores higher than 33% of stocks. Additionally, Heron Therapeutics Inc scored a 80 in the Healthcare sector, ranking it higher than 80% of stocks in that sector.

Overall Score - 33
HRTX has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on HRTX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 33 would rank higher than 33 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Heron Therapeutics Inc Stock Today?

Heron Therapeutics Inc (HRTX) stock is trading at $1.26 as of 9:36 AM on Tuesday, Nov 28, a decline of -$0.06, or -4.55% from the previous closing price of $1.32. The stock has traded between $1.13 and $1.26 so far today. Volume today is low. So far 2,315 shares have traded compared to average volume of 3,676,362 shares. Click Here to get the full Stock Report for Heron Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App